SE436026B - Forfarande for framstellning av 13,14-dehydroprostaglandiner - Google Patents

Forfarande for framstellning av 13,14-dehydroprostaglandiner

Info

Publication number
SE436026B
SE436026B SE7706310A SE7706310A SE436026B SE 436026 B SE436026 B SE 436026B SE 7706310 A SE7706310 A SE 7706310A SE 7706310 A SE7706310 A SE 7706310A SE 436026 B SE436026 B SE 436026B
Authority
SE
Sweden
Prior art keywords
dehydroprostaglandines
procedure
preparation
Prior art date
Application number
SE7706310A
Other languages
English (en)
Swedish (sv)
Other versions
SE7706310L (sv
Inventor
C Gandolfi
F Faustini
W Moretti
M M Usardi
R Ceserani
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2382676A external-priority patent/IT1060884B/it
Priority claimed from IT3045876A external-priority patent/IT1065450B/it
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of SE7706310L publication Critical patent/SE7706310L/xx
Publication of SE436026B publication Critical patent/SE436026B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
SE7706310A 1976-06-01 1977-05-31 Forfarande for framstellning av 13,14-dehydroprostaglandiner SE436026B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2382676A IT1060884B (it) 1976-06-01 1976-06-01 Aromatiche prostaglandine
IT3045876A IT1065450B (it) 1976-12-16 1976-12-16 Oxaprostaglandine

Publications (2)

Publication Number Publication Date
SE7706310L SE7706310L (sv) 1977-12-02
SE436026B true SE436026B (sv) 1984-11-05

Family

ID=26328426

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7706310A SE436026B (sv) 1976-06-01 1977-05-31 Forfarande for framstellning av 13,14-dehydroprostaglandiner

Country Status (18)

Country Link
US (1) US4195183A (cs)
JP (1) JPS52148044A (cs)
AT (2) AT356302B (cs)
AU (1) AU509127B2 (cs)
BE (1) BE855236A (cs)
CA (1) CA1115700A (cs)
CH (1) CH634831A5 (cs)
CS (1) CS192484B2 (cs)
DE (1) DE2721534A1 (cs)
DK (1) DK233377A (cs)
FR (1) FR2368473A1 (cs)
GB (1) GB1583263A (cs)
HU (1) HU181424B (cs)
IL (1) IL51877A (cs)
NL (1) NL7705701A (cs)
NZ (1) NZ184187A (cs)
SE (1) SE436026B (cs)
SU (1) SU932985A3 (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH656877A5 (de) * 1981-11-27 1986-07-31 Erba Farmitalia Optisch aktive oder racemische prostaglandinderivate.
US5972991A (en) 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
WO2003074481A2 (en) * 2002-03-01 2003-09-12 Allergan, Inc. Preparation of prostamides
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
WO2010102078A1 (en) 2009-03-04 2010-09-10 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
WO2011046569A1 (en) * 2009-10-16 2011-04-21 Cayman Chemical Company Process for the preparation of f-series prostaglandins
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
JP2020034682A (ja) 2018-08-29 2020-03-05 キオクシア株式会社 露光方法、露光制御装置および半導体装置の製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU501803B2 (en) * 1975-03-21 1979-06-28 Farmitalia Carlo Erba S.P.A. Fluoro-prostaglandins
ZA765031B (en) * 1975-09-10 1977-10-26 Univ Chicago Fluorinated prostaglandins and related compounds and chemical process

Also Published As

Publication number Publication date
AU2465677A (en) 1978-11-02
GB1583263A (en) 1981-01-21
AT367747B (de) 1982-07-26
CA1115700A (en) 1982-01-05
FR2368473A1 (fr) 1978-05-19
AU509127B2 (en) 1980-04-24
CH634831A5 (en) 1983-02-28
HU181424B (en) 1983-07-28
US4195183A (en) 1980-03-25
SE7706310L (sv) 1977-12-02
ATA333477A (de) 1979-09-15
DE2721534A1 (de) 1977-12-15
SU932985A3 (ru) 1982-05-30
DK233377A (da) 1977-12-02
CS192484B2 (en) 1979-08-31
NL7705701A (nl) 1977-12-05
JPS52148044A (en) 1977-12-08
ATA383179A (de) 1981-12-15
NZ184187A (en) 1978-07-28
BE855236A (fr) 1977-11-30
JPS6140662B2 (cs) 1986-09-10
IL51877A (en) 1981-09-13
IL51877A0 (en) 1977-06-30
FR2368473B1 (cs) 1981-09-11
AT356302B (de) 1980-04-25

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
AR224095A1 (es) Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3
NO148959C (no) Fremgangsmaate ved fremstilling av tumor-motvirkende antracyklinglykosidantibiotika, betegnet ma 144
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
MX4161E (es) Procedimiento de preparacion de compuestos de amino-alcoxi-4(2h)-piranona-2,3 substituidos condensados-5,62
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
RO77485A (ro) Procedeu pentru prepararea 1,2,3-tiadiazol-3-in-5-ilidenureelor
RO75589A (ro) Procedeu pentru prepararea 2,6-metan-2h-1-benzoxocinei
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO771870L (no) Fremgangsm}te for fremstilling av 3,4-dihydro-2-metyl-4-okso-2h-1,2-benzotiazin-3-karboksylsyre-1,1-dioksyd
SE7804878L (sv) Forfarande for framstellning av 1,2-dikloretan
SE7707125L (sv) Forfarande for framstellning av 7-(alfa-(2,3, - dihydro-2-oxo-1h- bensimidazol -1- ylkarbomyl-amino) arylacetamido ) cefalasporiner
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE432765B (sv) Forfarande for framstellning av 2,9-dioxatricyklo/4,3,1,0?723?72,?727/dekaner
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
SE426947B (sv) Forfarande for framstellning av 3,5,5-trimetyl-hexanoyl-ferrocen
NO774503L (no) Fremgangsmaate for fremstilling av oktahydro-indolo(2,3,a)-chinoliziner
SE426067B (sv) Forfarande for framstellning av 9-hydroxi-7,8,9,10-tetrahydro-6h-dibenso (b,d) pyraner och -pyranoner
NO772809L (no) Fremgangsm}te for fremstilling av 2,6-diterti{rt-butylfenol

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7706310-5

Effective date: 19890721

Format of ref document f/p: F